Diabetes Mellitus Type 2 (T2DM) is a non-communicable and multifactorial disease. It is a leading cause of premature deaths worldwide. Inflammatory cytokines are reported that they have potential to enhance insulin resistance and hence T2DM. The current research was taken to investigate the possible role of inflammatory mediators: Tumor Necrosis Factor (TNF-α) and White blood cells (WBC’s) in mobilizing biological molecules mainly immunological nature. A total of 320 subjects were selected in this study among them 160 were T2DM cases and 160 were healthy controls. Serum concentration of Tumor Necrosis Factor-a (TNF-α) was quantified by ELISA method, WBC count was measured on Sysmax (Germany) hematology analyzer, biochemical and Immunoassay ...
A state of subclinical systemic inflammation is characteristically present in obesity/insulin resist...
A state of subclinical systemic inflammation is characteristically present in obesity/insulin resist...
A state of subclinical systemic inflammation is characteristically present in obesity/insulin resist...
Diabetes Mellitus Type 2 (T2DM) is a non-communicable and multifactorial disease. It is a leading ca...
Diabetes Mellitus Type 2 (T2DM) is a non-communicable and multifactorial disease. It is a leading ca...
Type 2 diabetes mellitus (T2DM) is a multifactorial non-communicable disease that is characterized b...
The pathogenesis and complications of type 2 diabetes (T2DM) are closely linked with defective gluco...
The pathogenesis and complications of type 2 diabetes (T2DM) are closely linked with defective gluco...
The pathogenesis and complications of type 2 diabetes (T2DM) are closely linked with defective gluco...
The pathogenesis and complications of type 2 diabetes (T2DM) are closely linked with defective gluco...
Type 2 diabetes mellitus (T2DM) is increasingly common worldwide. Related complications account for ...
Background: The role of the immune system in insulin resistance associated with type 2 diabetes has ...
Objective: T2DM (Type 2 Diabetes Mellitus) and IR (Insulin Resistance) have an association with each...
A state of subclinical systemic inflammation is characteristically present in obesity/insulin resist...
A state of subclinical systemic inflammation is characteristically present in obesity/insulin resist...
A state of subclinical systemic inflammation is characteristically present in obesity/insulin resist...
A state of subclinical systemic inflammation is characteristically present in obesity/insulin resist...
A state of subclinical systemic inflammation is characteristically present in obesity/insulin resist...
Diabetes Mellitus Type 2 (T2DM) is a non-communicable and multifactorial disease. It is a leading ca...
Diabetes Mellitus Type 2 (T2DM) is a non-communicable and multifactorial disease. It is a leading ca...
Type 2 diabetes mellitus (T2DM) is a multifactorial non-communicable disease that is characterized b...
The pathogenesis and complications of type 2 diabetes (T2DM) are closely linked with defective gluco...
The pathogenesis and complications of type 2 diabetes (T2DM) are closely linked with defective gluco...
The pathogenesis and complications of type 2 diabetes (T2DM) are closely linked with defective gluco...
The pathogenesis and complications of type 2 diabetes (T2DM) are closely linked with defective gluco...
Type 2 diabetes mellitus (T2DM) is increasingly common worldwide. Related complications account for ...
Background: The role of the immune system in insulin resistance associated with type 2 diabetes has ...
Objective: T2DM (Type 2 Diabetes Mellitus) and IR (Insulin Resistance) have an association with each...
A state of subclinical systemic inflammation is characteristically present in obesity/insulin resist...
A state of subclinical systemic inflammation is characteristically present in obesity/insulin resist...
A state of subclinical systemic inflammation is characteristically present in obesity/insulin resist...
A state of subclinical systemic inflammation is characteristically present in obesity/insulin resist...
A state of subclinical systemic inflammation is characteristically present in obesity/insulin resist...